vTv Therapeutics (VTVT)

• Market cap: $39.1M
• 1 day: 3.03%
• 5 days: -0.20%
• 1 month: -3.23%
• 3 months: 5.06%
• 6 months: -21.51%
• Year to date: 38.52%
• 1 year: 70.00%
• 5 years: -76.63%
• 10 years: -96.57%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.

Employees: 16

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

19% more capital invested

Capital invested by funds: $6.16M [Q2] → $7.34M (+$1.17M) [Q3]

7.96% more ownership

Funds ownership: 14.36% [Q2] → 22.32% (+7.96%) [Q3]

5% more funds holding

Funds holding: 19 [Q2] → 20 (+1) [Q3]

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $35 134% upside
• Avg. target: $35 134% upside
• High target: $35 134% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Alliance Global Partners James Molloy 0% 1-year accuracy 0 / 10 met price target

134% upside $35

Buy Initiated

9 Dec 2024